Table 2. Main results of the eligible studies.
Study | Diagnosis | Specimen type | OPN variants | Cases | Controls | Unit | Detection method | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | N | Mean | SD | N | ||||||
Shiratori B 2014 | PTB | Plasma | NR | 150.73 | 53.43 | 37 | 74.23 | 19.34 | 30 | ng/mL | ELISA |
Shiratori B 2017 | PTB | Plasma | Full-length and cleaved OPN | 59.46 | 37.70 | 36 | 40.05 | 27.72 | 19 | ng/mL | ELISA |
Inomata SI 2003 | PTB | Plasma | Full-length OPN | 433.0 | 259.0 | 47 | 170.0 | 65.9 | 25 | ng/mL | ELISA |
Zhang YT 2018 | PTB | Serum | NR | 657.5 | 315.6 | 48 | 170.3 | 114.2 | 53 | ng/mL | ELISA |
Wu TF 2017 | Spinal tuberculosis | Serum | NR | 538.94 | 258.41 | 51 | 143.12 | 78.31 | 63 | ng/mL | ELISA |
Ding YL 2017 | PTB | Plasma | NR | 563.2 | 123.4 | 20 | 40.2 | 11.2 | 20 | ng/mL | ELISA |
Hao XL 2016 | Smear-negative PTB | Serum | NR | 712.62 | 335.75 | 43 | 185.34 | 120.23 | 40 | pg/mL | ELISA |
Cui JX 2014 | PTB | Serum | NR | 588.42 | 271.67 | 80 | 169.12 | 97.43 | 100 | ng/mL | ELISA |
Guo SX 2013 | PTB | Serum | NR | 683.21 | 321.76 | 42 | 168.46 | 117.31 | 36 | ng/mL | ELISA |
Gan B 2009 | TB | Plasma | NR | 160.54 | 32.42 | 44 | 76.18 | 20.69 | 20 | ng/mL | ELISA |
Du H 2020 | PTB | Serum | NR | 564.52 | 126.51 | 50 | 40.26 | 11.72 | 20 | ng/mL | ELISA |
Wang Q 2019 | PTB | Serum | NR | 663.45 | 94.20 | 92 | 384.14 | 37.15 | 50 | ng/mL | ELISA |
Wu YX 2019 | PTB | Serum | NR | 663.9 | 282.6 | 90 | 356.4 | 130.2 | 90 | pg/mL | ELISA |
Feng PL 2017 | PTB | Serum | NR | 691.54 | 102.72 | 55 | 171.94 | 36.83 | 60 | ng/mL | ELISA |
Yuan Y 2016 | PTB | Serum | NR | 683.2 | 321.8 | 52 | 168.5 | 117.3 | 45 | ng/mL | ELISA |
Qiao YF 2013 | PTB | Serum | NR | 652.4 | 270.8 | 62 | 155.6 | 107.2 | 35 | ng/mL | ELISA |
Sun XX 2016 | PTB | Serum | NR | 652.31 | 264.74 | 84 | 152.93 | 113.26 | 80 | ng/L | ELISA |
PTB, pulmonary tuberculosis; TB, tuberculosis; SD, standard deviation; NR, not reported; ELISA, enzyme-linked immunosorbent assay.